Lilia-Celine Lozada
Stock Analyst at JP Morgan
(2.40)
# 2,435
Out of 5,128 analysts
8
Total ratings
60%
Success rate
15.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $20 → $22 | $22.93 | -4.06% | 1 | Dec 16, 2025 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $41.77 | +14.92% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $12.37 | -2.99% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $2.86 | +74.83% | 2 | Nov 7, 2025 |
Envista Holdings
Dec 16, 2025
Maintains: Neutral
Price Target: $20 → $22
Current: $22.93
Upside: -4.06%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $41.77
Upside: +14.92%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $12.37
Upside: -2.99%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $2.86
Upside: +74.83%